Cargando…
Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editorial Office of Gut and Liver
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221852/ https://www.ncbi.nlm.nih.gov/pubmed/28053295 http://dx.doi.org/10.5009/gnl16574 |
| _version_ | 1782492889046056960 |
|---|---|
| author | Eun, Chang Soo |
| author_facet | Eun, Chang Soo |
| author_sort | Eun, Chang Soo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5221852 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Editorial Office of Gut and Liver |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-52218522017-01-13 Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients? Eun, Chang Soo Gut Liver Editorial Editorial Office of Gut and Liver 2017-01 2017-01-15 /pmc/articles/PMC5221852/ /pubmed/28053295 http://dx.doi.org/10.5009/gnl16574 Text en Copyright © 2017 by The Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, Korean Pancreatobiliary Association, and Korean Society of Gastrointestinal Cancer. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Eun, Chang Soo Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients? |
| title | Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients? |
| title_full | Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients? |
| title_fullStr | Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients? |
| title_full_unstemmed | Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients? |
| title_short | Is the Therapeutic Drug Monitoring of Anti-TNF Agents Necessary in Korean Inflammatory Bowel Disease Patients? |
| title_sort | is the therapeutic drug monitoring of anti-tnf agents necessary in korean inflammatory bowel disease patients? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5221852/ https://www.ncbi.nlm.nih.gov/pubmed/28053295 http://dx.doi.org/10.5009/gnl16574 |
| work_keys_str_mv | AT eunchangsoo isthetherapeuticdrugmonitoringofantitnfagentsnecessaryinkoreaninflammatoryboweldiseasepatients |